Ashim Paul

983 total citations
38 papers, 814 citations indexed

About

Ashim Paul is a scholar working on Molecular Biology, Physiology and Biomaterials. According to data from OpenAlex, Ashim Paul has authored 38 papers receiving a total of 814 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 23 papers in Physiology and 14 papers in Biomaterials. Recurrent topics in Ashim Paul's work include Alzheimer's disease research and treatments (20 papers), Supramolecular Self-Assembly in Materials (14 papers) and Chemical Synthesis and Analysis (13 papers). Ashim Paul is often cited by papers focused on Alzheimer's disease research and treatments (20 papers), Supramolecular Self-Assembly in Materials (14 papers) and Chemical Synthesis and Analysis (13 papers). Ashim Paul collaborates with scholars based in India, Israel and United States. Ashim Paul's co-authors include Bhubaneswar Mandal, Daniel Segal, Ehud Gazit, Ravindra Venkatramani, Rajaram Swaminathan, Kishore Thalluri, Krishnakumar Velayudhannair, Sayanti Brahmachari, Moran Frenkel‐Pinter and Li Gao and has published in prestigious journals such as Angewandte Chemie International Edition, ACS Nano and Chemical Communications.

In The Last Decade

Ashim Paul

38 papers receiving 806 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashim Paul India 16 425 376 169 117 107 38 814
Anna K. Tickler Australia 10 450 1.1× 426 1.1× 263 1.6× 122 1.0× 90 0.8× 10 848
Francesco Attanasio Italy 19 354 0.8× 373 1.0× 81 0.5× 119 1.0× 79 0.7× 48 782
Chanki Ha United States 8 330 0.8× 400 1.1× 109 0.6× 77 0.7× 74 0.7× 10 749
Dahabada H. J. Lopes United States 13 581 1.4× 564 1.5× 114 0.7× 67 0.6× 135 1.3× 19 1.0k
Weihong Du China 22 612 1.4× 452 1.2× 72 0.4× 133 1.1× 88 0.8× 74 1.2k
Zuzana Bednáriková Slovakia 18 397 0.9× 452 1.2× 125 0.7× 85 0.7× 114 1.1× 49 863
Wei‐Hui Wu China 14 303 0.7× 568 1.5× 113 0.7× 44 0.4× 128 1.2× 19 803
Bruno Aliès France 21 426 1.0× 708 1.9× 145 0.9× 79 0.7× 143 1.3× 33 1.2k
Katarína Šipošová Slovakia 18 311 0.7× 324 0.9× 83 0.5× 106 0.9× 149 1.4× 46 794
Ken‐ichi Akagi Japan 17 412 1.0× 412 1.1× 66 0.4× 49 0.4× 185 1.7× 35 931

Countries citing papers authored by Ashim Paul

Since Specialization
Citations

This map shows the geographic impact of Ashim Paul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashim Paul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashim Paul more than expected).

Fields of papers citing papers by Ashim Paul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashim Paul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashim Paul. The network helps show where Ashim Paul may publish in the future.

Co-authorship network of co-authors of Ashim Paul

This figure shows the co-authorship network connecting the top 25 collaborators of Ashim Paul. A scholar is included among the top collaborators of Ashim Paul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashim Paul. Ashim Paul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nikelshparg, Evelina I., Ashim Paul, Vijay Kumar, et al.. (2025). Self-Assembly of Accumulated Sphingolipids into Cytotoxic Fibrils in Globoid Cell Leukodystrophy and Their Inhibition by Small Molecules In Vitro. ACS Nano. 19(27). 25180–25203. 1 indexed citations
2.
Paul, Ashim, Elad Arad, Hamutal Engel, et al.. (2021). Inhibition of tau amyloid formation and disruption of its preformed fibrils by Naphthoquinone–Dopamine hybrid. FEBS Journal. 288(14). 4267–4290. 19 indexed citations
3.
Wettstein, Lukas, Elad Arad, Ashim Paul, et al.. (2021). Dual concentration-dependent effect of ascorbic acid on PAP(248–286) amyloid formation and SEVI-mediated HIV infection. RSC Chemical Biology. 2(5). 1534–1545. 1 indexed citations
4.
Zacco, Elsa, et al.. (2021). Glycans to improve efficacy and solubility of protein aggregation inhibitors. Neural Regeneration Research. 16(11). 2215–2215. 6 indexed citations
5.
Paul, Ashim, et al.. (2020). Naphthoquinone–Dopamine Hybrids Inhibit α‐Synuclein Aggregation, Disrupt Preformed Fibrils, and Attenuate Aggregate‐Induced Toxicity. Chemistry - A European Journal. 26(69). 16486–16496. 15 indexed citations
6.
Gao, Li, Wuyue Yang, Wenhao Li, et al.. (2020). Rational Design of a Cocktail of Inhibitors against Aβ Aggregation. Chemistry - A European Journal. 26(16). 3499–3503. 14 indexed citations
7.
Paul, Ashim, et al.. (2020). Tryptophan-galactosylamine conjugates inhibit and disaggregate amyloid fibrils of Aβ42 and hIAPP peptides while reducing their toxicity. Communications Biology. 3(1). 484–484. 33 indexed citations
8.
Paul, Ashim, et al.. (2020). An amyloidogenic hexapeptide from the cataract-associated γD-crystallin is a model for the full-length protein and is inhibited by naphthoquinone-tryptophan hybrids. International Journal of Biological Macromolecules. 157. 424–433. 3 indexed citations
9.
Paul, Ashim, et al.. (2019). Novel model of secreted human tau protein reveals the impact of the abnormal N-glycosylation of tau on its aggregation propensity. Scientific Reports. 9(1). 2254–2254. 38 indexed citations
10.
Paul, Ashim, et al.. (2019). Naphthoquinone Tryptophan Hybrids: A Promising Small Molecule Scaffold for Mitigating Aggregation of Amyloidogenic Proteins and Peptides. Frontiers in Cell and Developmental Biology. 7. 242–242. 27 indexed citations
11.
Paul, Ashim, Bo‐Dou Zhang, Li Gao, et al.. (2019). Novel Mannitol-Based Small Molecules for Inhibiting Aggregation of α-Synuclein Amyloids in Parkinson's Disease. Frontiers in Molecular Biosciences. 6. 16–16. 42 indexed citations
12.
Velayudhannair, Krishnakumar, Ashim Paul, Ehud Gazit, & Daniel Segal. (2018). Mechanistic insights into remodeled Tau-derived PHF6 peptide fibrils by Naphthoquinone-Tryptophan hybrids. Scientific Reports. 8(1). 71–71. 49 indexed citations
13.
Paul, Ashim, et al.. (2017). Disaggregation of Amylin Aggregate by Novel Conformationally Restricted Aminobenzoic Acid containing α/β and α/γ Hybrid Peptidomimetics. Scientific Reports. 7(1). 40095–40095. 41 indexed citations
14.
Paul, Ashim, et al.. (2017). Near UV-Visible electronic absorption originating from charged amino acids in a monomeric protein. Chemical Science. 8(8). 5416–5433. 159 indexed citations
15.
Paul, Ashim, et al.. (2016). Investigation of Novel Spectroscopic Features in the Near Ultraviolet Region Arising from Non-Aromatic Amino Acids in Peptides and Proteins. Biophysical Journal. 110(3). 489a–489a. 2 indexed citations
16.
Paul, Ashim, et al.. (2016). Protective effects of β‐sheet breaker α/β‐hybrid peptide against amyloid β‐induced neuronal apoptosis in vitro. Chemical Biology & Drug Design. 89(6). 888–900. 13 indexed citations
17.
Paul, Ashim, et al.. (2014). Inhibition of Alzheimer's amyloid-β peptide aggregation and its disruption by a conformationally restricted α/β hybrid peptide. Chemical Communications. 51(12). 2245–2248. 56 indexed citations
18.
Saha, Abhijit, et al.. (2013). Phenolic Ester Mediated Oligopeptide Synthesis Promoted by HOBt. Protein and Peptide Letters. 21(2). 188–193. 2 indexed citations
19.
Paul, Ashim, et al.. (2013). Modulation of Aggregation Propensity of Aβ38 by Site Specific Multiple Proline Substitution. International Journal of Peptide Research and Therapeutics. 19(4). 365–371. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna K. Tickler Breakdown of academic impact, for papers by Francesco Attanasio Breakdown of academic impact, for papers by Chanki Ha Breakdown of academic impact, for papers by Dahabada H. J. Lopes Breakdown of academic impact, for papers by Weihong Du Breakdown of academic impact, for papers by Zuzana Bednáriková Breakdown of academic impact, for papers by Wei‐Hui Wu Breakdown of academic impact, for papers by Bruno Aliès Breakdown of academic impact, for papers by Katarína Šipošová Breakdown of academic impact, for papers by Ken‐ichi Akagi
Rankless by CCL
2026